NFKB1 and B-cell chronic lymphocytic leukemia: Given that both CpG ODN and CD40L enhance NF-κB binding [reviewed in 18 and 19] and promote IL21R expression in CLL cells [9, 16], we hypothesized that NF-κB was involved in upregulation of IL21R by CpG-685.